Ketamine, a noncompetitive N-methyl-D-aspartate receptor antagonist, is associated with chronic abuse leading to schizophrenia-like cognitive deficits. The gut-brain axis may play a role in mediating substance-induced neurotoxicity; however, its involvement in ketamine-induced cognitive impairment remains poorly understood. Here, chronic ketamine exposure was administered intraperitoneally to C57BL/6N mice to examine its effects on gut microbiota homeostasis and associated amino acid metabolism. Cognitive deficits were evaluated using the Y-maze and novel object recognition (NOR) tests. Hippocampal ultrastructure was assessed by transmission electron microscopy (TEM). Multi-omics integration included 16S rRNA sequencing, untargeted and targeted plasma metabolomics, and Spearman correlation analysis. The results showed that ketamine-exposed mice exhibited significant cognitive impairments, including impaired spontaneous alternation in the Y-maze (P < 0.05) and a reduced discrimination index in the NOR test (P < 0.01). TEM analysis revealed hippocampal mitochondrial damage, accompanied by chromatin condensation. Gut microbiota analysis indicated dysbiosis, with a notable increase in Lachnospiraceae, Bacteroidaceae, Helicobacteraceae, and Rikenellaceae and a decrease in Verrucomicrobiaceae and Prevotellaceae at the family level. Plasma amino acid levels were also disrupted, with a significant decrease in L-glutamine, L-lysine, L-threonine and an increase in L-cysteic acid. Furthermore, strong correlations were observed between the abundance of Bacteroides, branched-chain amino acids (BCAAs), and cognitive scores (|ρ| > 0.6, P < 0.05). This study identifies the microbiota-amino acid-mitochondrial axis as the underlying mechanism driving ketamine-induced neurotoxicity. It highlights the correlation between gut microbiota-associated amino acid reprogramming and this process, offering potential targets for microbiome-based interventions to combat substance-related cognitive impairments.
Fraction ZB30 (the 30% ethanol elution of the ethanol extract from Zanthoxylum bungeanum husks through AB-8 macroporous adsorption resin) exhibited the highest total polyphenol and flavonoid contents. Furthermore, fraction ZB30 rich in polyphenols from Zanthoxylum bungeanum husks not only exerted lipid-lowering effects via the mdt-15/sbp-1 signaling pathway but also demonstrated antioxidant activity by upregulating the expression of oxidative stress-related genes such as daf-2, daf-16, ctl-2, skn-1, and sod-3. Consequently, fraction ZB30 rich in polyphenols from Zanthoxylum bungeanum husks might hold significant potential for development and utilization in the field of lipid reduction and weight management.
In this study, fraction ZB30 (the 30% ethanol elution of the ethanol extract from Zanthoxylum bungeanum husks through AB-8 macroporous adsorption resin) could significantly reduce the triglyceride levels in high-fat Caenorhabditis elegans, which might contribute to the polyphenols such as rutin, isoquercitrin, isorhamnetin-3-O-glucoside, etc, analyzed by UPLC-Q-TOF-MS. Furthermore, through RT-qPCR experiments, it was speculated that the lipid-lowering effect of fraction ZB30 rich in polyphenols from Zanthoxylum bungeanum husks on Caenorhabditis elegans was mainly exerted through the mdt-15/sbp-1 signaling pathway. Moreover, using ABTS+• and DPPH•free radicals, fraction ZB30 rich in polyphenols from Zanthoxylum bungeanum husks exhibited certain antioxidant activities. The results of in vivo antioxidant activity showed that the group treated with fraction ZB30 significantly prolonged the lifespan of high-fat Caenorhabditis elegans, and fraction ZB30 rich in polyphenols from Zanthoxylum bungeanum husks could significantly reduce the level of reactive oxygen species (ROS) in high-fat Caenorhabditis elegans. Fraction ZB30 enhanced antioxidant stress resistance by increasing T-SOD, CAT, and GSH Px antioxidant enzyme levels and reducing MDA accumulation. RT-qPCR results showed that fraction ZB30 rich in polyphenols from Zanthoxylum bungeanum husks upregulated the expression of oxidative stress genes such as daf-2, daf-16, ctl-2, skn-1, and sod-3.
17 September 2026 in Revista Brasileira de Farmacognosia
Dental caries continues to be a serious worldwide public health issue, with Streptococcus mutans ( S. mutans ) identified as the primary etiological pathogen. This study aimed to evaluate the anti-cariogenic potential of pinosylvin (PIN) against S. mutans . A combination of in vitro and in vitro experiments was performed to characterize the anti-cariogenic effects of PIN. In vitro assays were conducted to determine the impacts of PIN on the growth, bacterial adhesion, biofilm formation, and lactic acid synthesis of S. mutans . Quantitative real-time PCR (qRT-PCR) was applied to quantify the transcript abundance of key cariogenic virulence genes, including gtfB, gtfC , and gtfD . A rat dental caries model was adopted to assess the biosafety and in vitro anti-cariogenic efficacy of PIN. PIN inhibited the growth, bacterial adhesion, biofilm formation, and lactic acid synthesis of S. mutans . Consistent with these phenotypic alterations, qRT-PCR analysis demonstrated that PIN downregulated the expression of core cariogenic virulence genes gtfB, gtfC , and gtfD . In vivo , PIN exhibited favorable biocompatibility and anti-cariogenic effects in the rat caries model. Collectively, these findings suggest that PIN exerts anti-cariogenic activity against S. mutans by suppressing multiple virulence-associated phenotypes and downregulating key cariogenic genes. The in vivo findings further support its biocompatibility and potential anti-cariogenic effect. Nevertheless, the precise molecular mechanisms underlying these effects and suitable delivery strategies of PIN remain to be clarified in future studies.